// App-Quantinova.ai

187 : Updated Report of Real-World Use of Subcutaneous Abatacept in Canadian RA Patients: The Abatacept Best Care (ABC) Treat-To-Target (T2T) Study

Researchers

Presenter

  • Louis Bessette

Principal Investigators

  • Janet Pope

  • Isabelle Fortin

  • Emmanouil Rampakakis

  • John Sampalis

  • Youb Chalabi

Medical Centers

  • Institut de Rhumatologie, Montreal, QC, Canada

  • University of Western Ontario, St Joseph's Health Care, London,Canada

  • Centre de recherche du CHU de Quebec, Universite Laval, Quebec,Canada

  • CH Rimouski, Rimouski,Canada

Locations

  • Canada

Companies

  • JSS Medical Research

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Abatacept

Outcome

  • Unknown

Study Design

  • observational

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved